drugset / Trial / NCT07407985
A Clinical Study to Evaluate GK01 Cell Injection in Combination With PD-1 Monoclonal Antibody for Advanced Solid Tumors
Phase 1
Active not recruiting
15 enrolled
Tianjin Medical University Cancer Institute and Hospital
Beijing Geekgene Technology Co., LTD · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is a open-label, single-arm clinical trial designed to evaluate the safety, pharmacokinetic profile, and preliminary efficacy of the GK01 cell injection in combination with a PD-1 monoclonal antibody for the treatment of advanced solid tumors.
Timeline
- Start
- 2025-12-04
- Primary completion
- 2027-12-03
- Completion
- 2028-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GK01 | Cell therapy | — | — |